The AllTrials campaign is pushing for all data on drug trials to be made public — see the campaign statement.
If the public has all the evidence rather than a biased selection of evidence, then it will be possible to make better decisions.
There’s been a good start, but more people need to know about it and more people need to push for it.
Here is an interview with Ron Hochreiter, Assistant Professor at WU Vienna University Economics and Business.
In 25 words or less tell us what you do (using German words is cheating).
I consider myself as a data scientist (teaching and research) with roots in Mathematical Programming, i.e. Optimization under Uncertainty (Stochastic Programming). Read more →
R is a piece of software, but it is also a community.
The most visible aspect of the R community is help. This is also the most useful to new users. The initial sense of cooperation with R was driven mainly by people helping each other.
You don’t need to actively participate in order to benefit from the help venues — just watching can be very educational.
If you do ask a question, it is in your best interests to formulate the question well. There are numerous places that give you hints on how to ask a question well, including Circle 9 of The R Inferno and the R posting guide. Each venue has a slightly different culture, but the main principles are the same. Read more →
Online Math Degrees has a page of “100 savvy sites on statistics and quantitative analysis”. It has some that you recognize, some that you’ve hardly ever heard of.
The sites are divided into groups. I think the R section should have included R-bloggers, but what do I know?
I think it’s well worth strolling through.
People who worked and suffered and struggled for fame,
Some who succeeded and some who suffered in vain.
— from “Celluloid Heroes” by Ray Davies Read more →
